
Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit
Author(s) -
Richard Harrigan
Publication year - 2000
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200007070-00011
Subject(s) - medicine , regimen , protease inhibitor (pharmacology) , immunology , viral load , combination therapy , oncology , gastroenterology , antiretroviral therapy , virus